- STAT+: Tau in the spotlight at Alzheimer’s conferenceFrom STAT's AAIC in 30 newsletter: Researchers focus on tau, and progress on crossing the blood-brain barrier.STAT · 14d ago↗ source
- Deals, deals, deals; Biohaven takes on Eli Lilly; and moreWelcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan writes that US biotech companies are holding their cards close to the ...Endpoints · 16d ago↗ source
- Apnimed files for IPO as FDA reviews its sleep apnea drugApnimed is finally going forward with an IPO attempt after years of flirting with the milestone. The Cambridge, MA-based biotech revealed its Nasdaq plans on Friday night, following a strong six ...Endpoints